Research news

IBEC researchers uncover strategy to reduce chemotherapy side effects

Researchers at IBEC and IDIBELL have developed a light-regulated molecule that could improve chemotherapy treatments by controlling the activity of anticancer agents.

Chemotherapy – the use of cytotoxic agents to kill the rapidly proliferating cells in tumors – is one of our main tools in the fight against cancer. However, its effectiveness and the body’s tolerance of it is often dramatically limited: it can affect healthy areas rather than just the cancerous ones, which causes side effects.

Read more…

Other news

SOMMa partners gather for third 100xCiencia meeting

Today Spain’s Severo Ochoa Centres of Excellence – including IBEC – and the María de Maeztu Units of Excellence are at the CNIO in Madrid for 100xCiencia.3, the annual event of the SOMMa alliance.

This year’s 100xCiencia is devoted to ‘Bringing Science and Society’, and IBEC is participating with a poster about its outreach activities.

As well as representatives from the research centres and units, the event is being attended by politicians, journalists and civic figures to debate about the different aspects of how and why science is important for society.

Read more…